financetom
Business
financetom
/
Business
/
Rhythm Pharmaceuticals Insider Sold Shares Worth $1,248,490, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rhythm Pharmaceuticals Insider Sold Shares Worth $1,248,490, According to a Recent SEC Filing
Apr 10, 2025 2:37 PM

05:21 PM EDT, 04/10/2025 (MT Newswires) -- Pamela J. Cramer, Chief Human Resources Officer, on April 08, 2025, sold 20,760 shares in Rhythm Pharmaceuticals ( RYTM ) for $1,248,490. Following the Form 4 filing with the SEC, Cramer has control over a total of 19,209 common shares of the company, with 19,209 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649904/000110465925033821/xslF345X05/tm2512047-2_4seq1.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BofA to buy $9 bln residential mortgage loan from Canada's TD, source says
BofA to buy $9 bln residential mortgage loan from Canada's TD, source says
Feb 7, 2025
Feb 7 (Reuters) - Bank of America ( BAC ) has agreed to buy a $9 billion portfolio of residential mortgage loans from Canadian lender Toronto-Dominion Bank ( MLWIQXX ), a source familiar with the matter said on Friday. ...
Market Chatter: Magnite to Provide Programmatic Ad Sales Support to X
Market Chatter: Magnite to Provide Programmatic Ad Sales Support to X
Feb 7, 2025
02:19 PM EST, 02/07/2025 (MT Newswires) -- Magnite ( MGNI ) is collaborating with Elon Musk's X to boost the social media platform's programmatic advertising sales, Business Insider reported Friday, citing Magnite's ( MGNI ) spokesperson. The partnership gives advertisers an option to add or remove X's inventory from their media buys, the spokesperson reportedly said. Neither Magnite ( MGNI...
AbbVie Says FDA Approves Emblaveo Antibiotic to Treat Abdominal Infections
AbbVie Says FDA Approves Emblaveo Antibiotic to Treat Abdominal Infections
Feb 7, 2025
02:03 PM EST, 02/07/2025 (MT Newswires) -- AbbVie ( ABBV ) said Friday it received approval from the US Food and Drug Administration for its antibiotic Emblaveo for the treatment of adults with complicated intra-abdominal infections. The approval covers Emblaveo's use with metronidazole in patients who have limited or no alternative options to treat their infections, including those caused by...
AmEx says it identified 30 consumer accounts potentially tied to Iran's government
AmEx says it identified 30 consumer accounts potentially tied to Iran's government
Feb 7, 2025
Feb 7 (Reuters) - U.S. credit card giant American Express ( AXP ) said on Friday it had identified approximately 30 consumer accounts last year that might have been tied to the government of Iran. ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved